Skip to main content
. Author manuscript; available in PMC: 2024 Jul 29.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1593–1601. doi: 10.1158/1055-9965.EPI-21-1397

Figure 1.

Figure 1.

Comparison of the frequency of protein truncating variants (PTVs) in breast cancer genes for controls and breast cancer cases from the Ghana Breast Health Study (GBHS) and the Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) study (European and Asian ancestries combined). Includes genes with PTVs reported associated with risk of breast cancer at a Bayesian False Discovery Probability < 5% in BRIDGES1. See Supplemental Table 4 for more details.